Consenso sarcopenia IA Flashcards
(64 cards)
What is sarcopenia?
A progressive and generalised skeletal muscle disorder associated with increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality.
What are the main health risks associated with untreated sarcopenia?
- Increased risk of falls and fractures
- Impaired ability to perform activities of daily living
- Associated with cardiac disease
- Associated with respiratory disease
- Associated with cognitive impairment
- Leads to mobility disorders
- Contributes to lowered quality of life
- Loss of independence or need for long-term care placement
- Increased mortality
How does sarcopenia affect healthcare costs?
Sarcopenia increases risk for hospitalisation and raises the cost of care during hospitalisation.
How much more likely are older adults with sarcopenia to incur higher hospital costs compared to those without?
More than 5-fold more likely.
What are the key insights from EWGSOP2 regarding sarcopenia?
- Development of sarcopenia begins earlier in life
- Sarcopenia is now considered a muscle disease (muscle failure)
- Low muscle strength is a principal determinant
- Muscle mass and quality are mainly used in research, not clinical practice
- Sarcopenia is often overlooked and undertreated in mainstream practice
What is the primary parameter for diagnosing sarcopenia according to EWGSOP2?
Low muscle strength.
What criteria must be met to diagnose sarcopenia as severe?
- Low muscle strength
- Low muscle quantity or quality
- Low physical performance
What is the SARC-F questionnaire used for?
To elicit self-reports from patients on signs characteristic of sarcopenia.
What is the recommended method for case-finding in clinical practice for sarcopenia?
Use of the SARC-F questionnaire.
What are the three criteria for identifying probable sarcopenia?
- Low muscle strength
- Low muscle quantity or quality
- Low physical performance
True or False: Sarcopenia is primarily a condition associated only with older adults.
False.
What are the implications of identifying sarcopenia earlier in life?
It opens up opportunities for interventions that can prevent or delay the development of sarcopenia.
What factors contribute to the complexity of diagnosing sarcopenia?
- Determining what variables to measure
- How to measure them
- What cut-off points guide diagnosis and treatment
- Evaluating effects of therapeutic interventions
What does the term ‘muscle quality’ refer to in the context of sarcopenia?
Micro- and macroscopic aspects of muscle architecture and composition.
What are the recommended tools for measuring muscle strength in clinical practice?
- Grip strength test
- Chair stand test
What is the significance of muscle strength in predicting adverse outcomes related to sarcopenia?
Muscle strength is recognized as a better predictor of adverse outcomes than muscle mass.
Fill in the blank: Sarcopenia is often overlooked and ______ in mainstream practice.
undertreated
What are the potential drivers of disability in activities of daily living (ADL) associated with sarcopenia?
- Lower gait speed
- Chair stand performance
What is the aim of the EWGSOP2 updates regarding sarcopenia?
- Build a sarcopenia definition reflecting recent advances
- Identify variables that best detect sarcopenia
- Advise cut-off points for measured variables
- Recommend an updated screening and assessment pathway
What is the advantage of using the Ishii screening test?
It estimates the probability of sarcopenia using an equation-derived score based on age, grip strength, and calf circumference.
How does low physical performance relate to sarcopenia?
Detection of low physical performance predicts adverse outcomes and is used to identify the severity of sarcopenia.
What is the role of the European Geriatric Medicine Society (EuGMS) concerning EWGSOP2?
Organized EWGSOP2 and included experts to update sarcopenia definitions and diagnostic characteristics.
What is SARC-F?
A self-reported screening tool reflecting patient perceptions of adverse outcomes
SARC-F is used in multiple languages to assess the risk of sarcopenia.
What is the Ishii screening test used for?
To estimate the probability of sarcopenia using age, grip strength, and calf circumference
It is a more formal case-finding instrument preferred in clinical settings.